Congress is poised to enact the Inflation Reduction Act, a $740 billion reconciliation package that includes sweeping climate change, deficit reduction, and health policy provisions. In her latest Expert Perspective for the State Health & Value Strategies project, Sabrina Corlette reviews the health care changes and their implications for states.
New health policy research topped CHIR’s list of beach reads this July. For the latest monthly research roundup, we reviewed studies on marketplace enrollees’ denied claims, how marketplace coverage has benefitted small business and self-employed workers, and out-of-pocket spending on insulin.
Many of those losing their Medicaid eligibility after the COVID-19 public health emergency will have illnesses or conditions requiring uninterrupted access to health care services. In their latest Expert Perspective for the State Health & Value Strategies project, Sabrina Corlette and Jason Levitis outline several policy and operational changes states can make to ensure that people transitioning from Medicaid to the Marketplace can maintain continuity of care.
Employer-sponsored insurance is the largest source of health coverage in the U.S., but the employer market’s historic status as the “backbone” of the U.S. health care system is imperiled by rising health care costs. A public health insurance option could help reduce health care costs and expand access to coverage for people with job-based insurance, and has received increasing support among employers.
The ACA requires that most insurers and employers cover a set of preventive health services at no cost to enrollees. Estimates suggest that more than 150 million people have access to over 100 services such as cancer screenings, contraception, and vaccines without any out-of-pocket costs. A case pending in federal court threatens to cut off consumers’ access by allowing insurers to impose cost-sharing on these services or, in some cases, cease covering them altogether. CHIR’s Rachel Schwab takes a look at some of the currently free services in jeopardy.
Utilization management is one tool that insurers can use to help keep premiums in check, but it comes with significant tradeoffs for patients. CHIR’s Megan Houston considers the history and current landscape of utilization management tools, what they are used for and what policymakers are doing to keep them in check.
Following the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, analyses project up to half of women and girls in the U.S. between the ages of 15 and 44 will live in states that significantly restrict or ban abortion services. The scale and geographic reach of these bans intensifies questions about travel costs and access to these services. Employers are looking at ways to cover abortion-related travel costs for workers.
The U.S. Department of Health and Human Services recently approved a new Section 1332 waiver authorizing Colorado’s public option-style law. The waiver approval marks the first time the federal government has taken action to approve state legislation introducing new, more heavily regulated plans into Affordable Care Act marketplaces to compete against traditional plans. In a new post for the Commonwealth Fund, CHIR experts dive into the details of Colorado’s law and waiver, and what they mean for future state action.
The No Surprises Act (NSA) went into effect this year, providing new protections against surprise medical bills for patients who receive unanticipated out-of-network care. CHIR has analyzed state NSA implementation and enforcement schemes and published an interactive map for the Commonwealth Fund, providing details about policies such as state enforcement strategies and patient-provider dispute resolution. In the newest iteration of the map, CHIR added updates on state payment determination mechanisms and protections against surprise ground ambulance bills.
Health insurers have begun to submit their proposed premium rates for 2023, and they’re not looking pretty. CHIR’s Sabrina Corlette dives into what is driving hefty premium increases in her annual review of the rate justifications insurers submit to state insurance departments.
The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.
